Mangrove Partners
BMEZ icon

Mangrove Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Mangrove Partners’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-377,466
Closed -$6.2M – 377
2022
Q2 		$6.2M Buy
+377,466
New +$6.47M 0.3% 77

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $3.04B AUM 36.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
1607 Capital Partners
1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return
Raymond James & Associates
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Rivernorth Capital Management
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Quantedge Capital
Quantedge Capital Singapore $132M AUM 56.43% 1-Year Est. Return
City of London Investment Management
City of London Investment Management London, United Kingdom $1.66B AUM 59.71% 1-Year Est. Return

Mangrove Partners's BMEZ Position: Q3 2022 in Review

Mangrove Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2022, closing a stake of 377,466 shares — an estimated $6.2M sold.

Mangrove Partners first reported a position in BMEZ in Q2 2022 and held it in 1 quarter. The position peaked at $6.2M in Q2 2022. 75 funds tracked by Wall St. Rank hold BMEZ as of Q3 2022.

  • Mangrove Partners reported no remaining BlackRock Health Sciences Trust II position as of Q3 2022 after selling out during the quarter.
  • Mangrove Partners sold 377,466 BlackRock Health Sciences Trust II shares in Q3 2022, an estimated $6.2M.
  • Mangrove Partners first reported a position in BlackRock Health Sciences Trust II in Q2 2022 and held it in 1 quarter.
  • Mangrove Partners's BlackRock Health Sciences Trust II position peaked at $6.2M in Q2 2022.
  • 75 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2022.

Based on Mangrove Partners's 13F filing for Q3 2022, filed 14 Nov 2022.